2017 Feb 27
Sneaking a peek inside DIPG
A team headed by Mark Souweidane, M.D., has devised a new way to image brain tumors. Read more
2017 Feb 23
New Type of Genetic Mutation Identified in Cancer
A newly discovered type of genetic mutation that occurs frequently in cancer cells may provide clues about the disease’s origins and offer new therapeutic targets, according to new research from Weill Cornell Medicine and... Read more
2017 Feb 23
Weill Cornell expert, "General Hospital" actress unite to raise PV awareness
Finola Hughes from TV's "General Hospital" and Ellen K. Ritchie, M.D. are teaming up to raise awareness for myeloproliferative disorder polycythemia vera. Read more
2017 Feb 23
New type of genetic mutation identified in cancer
A study by Marcin Imielinski, M.D., Ph.D., illuminates a possible new type of driver of cancer: small (one-50 letter) insertions or deletions of DNA sequence, also called “indels,” in regions of the genome that do not code for proteins. Read more
2017 Feb 22
The RNA code comes into focus
Feature about epitranscriptomics highlights the work of Chris Mason and Samie Jaffrey. Read more
2017 Feb 17
Lobectomy in early NSCLC: Time to wrap up its storyline?
Nasser Altorki, M.D. weighs in on the role of lobectomy in early-stage non-small cell lung cancer. Read more
2017 Feb 17
Contributing to an international cancer corps
A team of radiologists, oncologists, surgeons and other physicians are partnering with the International Cancer Expert Corps (ICEC) to create a Weill Cornell Medicine hub of global outreach for cancer care. Read more
2017 Feb 15
New score predicts liver cancer after transplant
The MORAL score for hepatocellular carcinoma is highly predictive of recurrence-free survival and can accurately identify patients who should not undergo liver transplant with a living donor, according to Karim J. Halazun, M.D. Read more
2017 Feb 14
Scalp cooling can help some breast cancer patients retain hair
Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new study from UC San Francisco, Weill Cornell Medicine and three other medical centers. Read more
2017 Feb 10
We Are Weill Cornell Medicine: Dr. Christopher Barbieri
Christopher Barbieri, M.D., Ph.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2017 Feb 09
Collaboration Employs New Strategies to Study the Spread of Cancer
Video of If cancer didn’t metastasize, or spread, it would be easy to cure, says Dr. Lewis Cantley , the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. “We could merely cut it out, and... Read more
2017 Feb 09
Collaboration employs new strategies to study the spread of cancer
Feature about the new Center on the Physics of Cancer Metabolism collaboration between Ithaca and NYC. Read more
2017 Feb 09
Weill Cornell Medicine scientists seek to improve ovarian cancer therapies
Juan Cubillos-Ruiz and colleagues have been awarded a grant to define the role of a potentially crucial biomarker in the treatment of ovarian cancer tumors. Read more
2017 Feb 08
Medical Marvels: Life-saving treatment for chronic leukemia
Richard Furman, M.D. and patient Robert Frank Azopardi were recently featured on the abc7NY Medical Marvels series. Read more
2017 Feb 06
Old drug may provide new hope to melanoma patients
Diabetes drug phenformin shows promise as a treatment for melanoma, according to research from Lewis Cantley, Ph.D., and Jonathan Zippin, M.D., Ph.D. Read more
2017 Feb 02
Expert discusses upcoming agents to treat follicular lymphoma
John Leonard, M.D. discusses advancements in the treatment of follicular lymphoma. Read more
2017 Feb 01
Artificial Intelligence helps identify effective cancer drug combinations
Artificial intelligence (AI) can help scientists predict what combinations of already existing drugs may work in different types of cancer, according to two new studies from the lab of Olivier Elemento, Ph.D. Read more
2017 Jan 31
Grad student honored for teaching, cancer patient program
Peter DelNero, a doctoral candidate in biomedical engineering who works in the lab of Cornell University associate Claudia Fischbach-Teschl, Ph.D, has received the 2017 K. Patricia Cross Future Leaders Award. DelNero is one of eight graduate students nationwide to receive this prestigious award out of more than 250 nominees from 127 institutions. Read more
2017 Jan 30
Martin discusses ibrutinib-palbociclib combo in mantle cell lymphoma
Peter Martin, M.D., discusses the results of a trial testing the combination of ibrutinib and palbociclib for patients being treated for mantle cell lymphoma. Read more
2017 Jan 27
Jaffrey wins Abel Award
Dr. Samie Jaffrey, the Greenberg-Starr Professor and a professor of pharmacology at Weill Cornell Medicine, has received the 2017 John J. Abel Award in Pharmacology from the American Society for Pharmacology and Experimental Therapeutics. Read more
